Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Voriconazole for Injection

Approval Number

国药准字H20233364

Company海南海灵化学制药有限公司

Registration Date

May 25, 2023

Drug Information

Generic Name

注射用伏立康唑

Dosage Form

注射剂

Strength

0.2g

Drug Type

化学药品

Registration Date

May 25, 2023

Company Information

Applicant Company

Company Name海南海灵化学制药有限公司

Company Address

海口市南海大道281号

Manufacturing Company

Company Name

海南海灵化学制药有限公司;武汉启瑞药业有限公司

Company Address

海口市南海大道281号；湖北省武汉市东湖新技术开发区庙山小区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用伏立康唑 - NMPA 批准文号 | MedPath